Jennifer J. McIntosh

ORCID: 0000-0002-0299-9589
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Maternal and fetal healthcare
  • Neonatal Respiratory Health Research
  • Maternal and Perinatal Health Interventions
  • Preterm Birth and Chorioamnionitis
  • Prenatal Screening and Diagnostics
  • Assisted Reproductive Technology and Twin Pregnancy
  • Infant Development and Preterm Care
  • Platelet Disorders and Treatments
  • Child Nutrition and Feeding Issues
  • Inflammatory Biomarkers in Disease Prognosis
  • Cardiovascular Issues in Pregnancy
  • Hemoglobinopathies and Related Disorders
  • Breastfeeding Practices and Influences
  • Complement system in diseases
  • Cardiovascular Disease and Adiposity
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Global Maternal and Child Health
  • Gestational Diabetes Research and Management
  • Blood Coagulation and Thrombosis Mechanisms
  • Dysphagia Assessment and Management
  • Clinical Nutrition and Gastroenterology
  • Venous Thromboembolism Diagnosis and Management
  • Nitric Oxide and Endothelin Effects

St. Vincent's Birmingham
2025

Medical College of Wisconsin
2015-2024

The University of Melbourne
2024

Leeds and York Partnership NHS Foundation Trust
2016-2021

John Hunter Hospital
2019

University of Oklahoma Health Sciences Center
2012-2018

Society for Maternal-Fetal Medicine
2016

Oklahoma City University
2014

University of Oklahoma
2014

Royal Hospital for Women
2014

Platelet counts of less than 150,000 per cubic millimeter during uncomplicated pregnancies are described as gestational thrombocytopenia if no alternative cause is identified. may be even lower in women with pregnancy-related complications. However, the occurrence and severity throughout pregnancy not defined.

10.1056/nejmoa1802897 article EN New England Journal of Medicine 2018-07-04

When a pregnant or postpartum woman presents with sudden and severe microangiopathic hemolytic anemia (MAHA) thrombocytopenia, three syndromes that require urgent care must be considered: (1) preeclampsia features/hemolysis, elevated liver function tests, low platelets (PE/HELLP) syndrome; (2) thrombotic thrombocytopenic purpura (TTP); (3) complement-mediated microangiopathy (C-TMA; also referred to as atypical hemolytic-uremic syndrome). The distinction among these is often unclear because...

10.1182/asheducation-2015.1.644 article EN Hematology 2015-12-05

The novel coronavirus disease 2019 (COVID-19) pandemic is causing a necessary, rapid adjustment within the field of obstetrics. Corticosteroid use mainstay therapy for those women delivering prematurely. Unfortunately, corticosteroid has been associated with worse outcomes in COVID-19 positive patients. Given this information, it necessary that obstetricians adjust practice to carefully weigh fetal benefits maternal risks. Therefore, our institution examined risks and altered...

10.1055/s-0040-1709684 article EN other-oa American Journal of Perinatology 2020-04-09

The novel coronavirus disease 2019 (COVID-19) is spreading fast and affecting the clinical workers at much higher risk than general population. Little known about COVID-19 effect on pregnant women; however, emerging evidence suggests they may be high of asymptomatic disease. In light projected shortage personal protective equipment (PPE), there an aggressive attempt conservation. obstetrics, guidelines PPE use are controversial differ among hospitals, globally, as well nationally. centers...

10.1055/s-0040-1709689 article EN other-oa American Journal of Perinatology 2020-04-10

10.1016/j.ajogmf.2021.100395 article EN American Journal of Obstetrics & Gynecology MFM 2021-05-13

ABSTRACT Background Emergency tracheal intubation is a common and high-risk procedure. Ketamine etomidate are sedative medicines commonly used to induce anesthesia for emergency intubation, but whether the induction medication affects patient outcomes uncertain. Research Question Does use of ketamine decrease incidence death among adults undergoing compared etomidate? Study Design Methods The Randomized trial Sedative choice Intubation (RSI) pragmatic, multicenter, unblinded, parallel-group,...

10.1101/2025.01.18.25320768 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2025-01-18

Preterm birth is a leading cause of infant mortality and child morbidity. not always unexpected, yet standard prenatal care does offer anticipatory education to parents at risk delivering preterm, which leaves unprepared make health choices during the pregnancy that can improve survival decrease morbidity in case preterm birth.To evaluate effect Preemie Prep for Parents (P3) program on maternal knowledge birth, preparation decision-making, anxiety.Recruitment this randomized clinical trial...

10.1001/jamapediatrics.2023.1586 article EN cc-by JAMA Pediatrics 2023-07-31

Multiple myeloma is typically a disease found in older women and rare diagnosis pregnancy.A 22-year-old woman, gravida 1 para 0, at 32 3/7 weeks of gestation presented with nausea, vomiting, rib back pain. She was hypertensive, anemic, thrombocytopenic, acute renal insufficiency, hypercalcemia laboratory parameters indicative pancreatitis. admitted to the obstetric intensive care unit working diagnoses preeclampsia, pancreatitis, nephrolithiasis, insufficiency. ultimately delivered because...

10.1097/aog.0000000000000361 article EN Obstetrics and Gynecology 2014-07-08

Hematologists are often needed to assist with the management of microangiopathic emergencies in pregnancy. A firm understanding diagnosis and preeclampsia severe features, hemolysis elevated liver enzyme low platelet syndrome, disseminated intravascular coagulation, which most common causes emergencies, is critical. However, being able consider when other (acute fatty pregnancy, congenital acquired thrombotic thrombocytopenic purpura, complement mediated microangiopathy, antiphospholipid...

10.1182/hematology.2023000500 article EN Hematology 2023-12-08

To determine the prevalence of Vitamin D (VitD) deficiency/insufficiency in mothers preterm neonates less than or equal to 32 weeks gestation and if current level VitD supplementation used for is appropriate.Prospective study from 10th May 2015 1st November 2016.Neonatal Intensive Care Unit at Canberra Hospital.Mothers their born gestation.Maternal levels were obtained within 3-4 days following delivery. Neonatal first life, age, 6-8 age. Demographic data on intake parenteral nutrition,...

10.1155/2019/8613414 article EN cc-by International Journal of Pediatrics 2019-01-01

Abstract Background Cardiovascular disease (CVD) is the leading cause of death in women every major developed country and most emerging nations. Complications pregnancy, including preeclampsia, indicate a subsequent increase cardiovascular risk. There may be primary care provider knowledge gap regarding preeclampsia as risk factor for CVD. The objective our study to determine how often internists at an academic institution inquire about history compared smoking, hypertension diabetes, when...

10.1186/s12905-020-01074-7 article EN cc-by BMC Women s Health 2020-10-01

Abstract Background Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is caused by antibodies against human platelet antigens (HPA). However, in many cases that meet clinical criteria for the condition, maternal sera do not have HPA antibodies. In studies examining whether leukocyte antigen (HLA) cause FNAIT, results are limited inconclusive. This study sought to examine clinically suspected FNAIT with absent had different HLA antibody strength specificity compared controls. Study...

10.1111/trf.17342 article EN Transfusion 2023-04-10

Syncytiotrophoblast stress is theorized to drive development of preeclampsia, but its molecular causes and consequences remain largely undefined. Multiple hormones implicated in preeclampsia signal via the Gαq cascade, leading hypothesis that excess signaling within syncytiotrophoblast may contribute. First, we present data supporting increased antioxidant responses villous samples human preeclamptic placenta. Second, was activated mouse placenta using Cre-lox DREADD methodologies....

10.1126/sciadv.adg8118 article EN cc-by-nc Science Advances 2023-12-01
Coming Soon ...